NCT02759991View on ClinicalTrials.gov

Effectiveness Trial to Evaluate Protection of Pregnant Women by Hepatitis E Vaccine in Bangladesh.

PHASE4CompletedINTERVENTIONAL
Enrollment

19,460

Participants

Timeline

Start Date

October 2, 2017

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions
Hepatitis E Infection
Interventions
DRUG

Hecolin

0.6ml Hecolin vaccine im. on day 0, 1 month and 6 months.

DRUG

Hepa-B

1ml Hepa-B vaccine im. on day 0, 1 month and 6 months.

Trial Locations (1)

Unknown

International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka

All Listed Sponsors
collaborator

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

collaborator

Sykehuset Innlandet HF

OTHER

lead

Norwegian Institute of Public Health

OTHER_GOV

NCT02759991 - Effectiveness Trial to Evaluate Protection of Pregnant Women by Hepatitis E Vaccine in Bangladesh. | Biotech Hunter | Biotech Hunter